FDA advisory panel narrowly rejects compounding of one peptide, back another

FDA panel considers loosening regulations on certain unapproved peptides

Inside the unconventional FDA panel that could reshape the peptide industry

What to Know About Peptides the FDA Is Considering for Use

FDA advisory panel recommends loosening restrictions on 2 unapproved peptides

FDA advisory panel narrowly rejects compounding of one peptide, back another

RFK Jr.’s peptide push narrowly gains backing from FDA advisers despite objections from scientists

FDA panel overrules its own scientists to ease access to unproven peptide injections

STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

La nueva batalla de los péptidos: la FDA revisa las sustancias promocionadas en redes sociales mientras sus científicos cuestionan su eficacia

US panel backs trendy peptides despite safety concerns